Guangdong Hybribio Biotech Co Ltd Asset Resilience Ratio

Latest as of June 2026: 3.82%

Guangdong Hybribio Biotech Co Ltd asset resilience ratio. Guangdong Hybribio Biotech Co Ltd (300639) has an Asset Resilience Ratio of 3.82% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300639 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥160.27 Million

≈ $23.45 Million USD Cash + Short-term Investments

Total Assets

CN¥4.20 Billion

≈ $614.42 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Guangdong Hybribio Biotech Co Ltd (2019–2025)

Asset resilience ratio of Guangdong Hybribio Biotech Co Ltd from 2019 to 2025. This chart shows how Guangdong Hybribio Biotech Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Guangdong Hybribio Biotech Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Hybribio Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300639 total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥160.27 Million	3.82%
Total Liquid Assets	CN¥160.27 Million	3.82%

Asset Resilience Insights

Limited Liquidity: Guangdong Hybribio Biotech Co Ltd maintains only 3.82% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Hybribio Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Hybribio Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Diagnósticos da América S.A SA:DASA3	Diagnostics & Research	10.42%
SMO ClinPlus Co. Ltd. SHE:301257	Diagnostics & Research	15.78%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Guangdong Hybribio Biotech Co Ltd Asset Resilience Ratio by Year (2019–2025)

Guangdong Hybribio Biotech Co Ltd asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Guangdong Hybribio Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.79%	CN¥240.15 Million ≈ $35.14 Million	CN¥4.15 Billion ≈ $606.93 Million	+0.38pp
2024-12-31	5.41%	CN¥250.29 Million ≈ $36.62 Million	CN¥4.62 Billion ≈ $676.49 Million	+0.05pp
2023-12-31	5.36%	CN¥307.05 Million ≈ $44.93 Million	CN¥5.73 Billion ≈ $837.86 Million	-0.39pp
2022-12-31	5.75%	CN¥387.06 Million ≈ $56.64 Million	CN¥6.73 Billion ≈ $984.98 Million	-10.25pp
2021-12-31	16.00%	CN¥677.14 Million ≈ $99.09 Million	CN¥4.23 Billion ≈ $619.18 Million	-14.10pp
2020-12-31	30.10%	CN¥860.00 Million ≈ $125.85 Million	CN¥2.86 Billion ≈ $418.06 Million	+29.72pp
2019-12-31	0.39%	CN¥5.00 Million ≈ $731.66K	CN¥1.30 Billion ≈ $189.79 Million	--

pp = percentage points

About Guangdong Hybribio Biotech Co Ltd

SHE:300639 China Diagnostics & Research

Market Cap

$539.24 Million

CN¥3.69 Billion CNY

Market Cap Rank

#11532 Global

#3216 in China

Share Price

CN¥5.70

Change (1 day)

+1.97%

52-Week Range

CN¥4.88 - CN¥8.81

All Time High

CN¥19.74